For research use only. Not for therapeutic Use.
SLF1081851（Cat No.:I043497）is a selective small molecule inhibitor that targets the protein kinase B (AKT), a key regulator of cell survival, growth, and metabolism. AKT is frequently dysregulated in various cancers and contributes to tumor progression, resistance to treatment, and metastasis. By inhibiting AKT, SLF1081851 aims to block the oncogenic signaling pathways that promote tumor cell proliferation and survival. This compound is being studied for its potential therapeutic benefits in cancers, particularly those with aberrant AKT activity, and may also have applications in metabolic disorders linked to AKT dysfunction.
| CAS Number | 2763730-97-6 |
| Synonyms | 3-[3-(4-decylphenyl)-1,2,4-oxadiazol-5-yl]propan-1-amine |
| Molecular Formula | C21H33N3O |
| Purity | ≥95% |
| IUPAC Name | 3-[3-(4-decylphenyl)-1,2,4-oxadiazol-5-yl]propan-1-amine |
| InChI | InChI=1S/C21H33N3O/c1-2-3-4-5-6-7-8-9-11-18-13-15-19(16-14-18)21-23-20(25-24-21)12-10-17-22/h13-16H,2-12,17,22H2,1H3 |
| InChIKey | VLTITRMWGPJCFJ-UHFFFAOYSA-N |
| SMILES | CCCCCCCCCCC1=CC=C(C=C1)C2=NOC(=N2)CCCN |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
